Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17M Sell
46,923
-1,094
-2% -$374K 5.76% 2
2026
Q1
$16.9M Sell
48,017
-2,380
-5% -$848K 5.66% 5
2025
Q4
$16.5M Buy
50,397
+1,083
+2% +$344K 5.1% 7
2025
Q3
$13.9M Sell
49,314
-6,684
-12% -$1.94M 4.41% 12
2025
Q2
$15.6M Sell
55,998
-12,754
-19% -$3.61M 4.35% 12
2025
Q1
$21.4M Buy
68,752
+2,780
+4% +$821K 5.29% 5
2024
Q4
$17.2M Buy
65,972
+6,257
+10% +$1.86M 4.29% 13
2024
Q3
$19.2M Buy
59,715
+3,735
+7% +$1.22M 4.56% 7
2024
Q2
$17.5M Buy
55,980
+663
+1% +$195K 4.72% 10
2024
Q1
$15.7M Sell
55,317
-1,397
-2% -$409K 4.25% 14
2023
Q4
$16.3M Sell
56,714
-1,028
-2% -$280K 4.65% 9
2023
Q3
$15.5M Buy
57,742
+20,630
+56% +$5.15M 4.75% 7
2023
Q2
$8.24M Buy
+37,112
New +$8.61M 2.54% 22

Other funds holding AMGN

Nepsis Inc's AMGN Position: Q2 2026 in Review

Nepsis Inc reduced its Amgen (AMGN) stake by 2.3% in Q2 2026, selling an estimated $374K and leaving 46,923 shares worth $17M. The position accounts for 5.76% of the portfolio, ranked #2.

Nepsis Inc first reported a position in AMGN in Q2 2023 and has held it in 13 quarters since. The position peaked at $21.4M in Q1 2025. 1,262 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Nepsis Inc held 46,923 shares of Amgen worth $17M as of Q2 2026.
  • Nepsis Inc sold 1,094 Amgen shares in Q2 2026, an estimated $374K.
  • Amgen made up 5.76% of Nepsis Inc's portfolio in Q2 2026, its #2 holding.
  • Nepsis Inc first reported a position in Amgen in Q2 2023 and has held it in 13 quarters since.
  • Nepsis Inc's Amgen position peaked at $21.4M in Q1 2025.
  • 1,262 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Nepsis Inc's 13F filing for Q2 2026, filed 14 Jul 2026.